John E. Monahan

13.3k citations
19 papers · 1.6k · 1 hit paper · h-index 12

Impact in

Papers in

    • PI3K/AKT/mTOR signaling in cancer 3
    • Ubiquitin and proteasome pathways 1
    • Cancer-related Molecular Pathways 3

John E. Monahan

19 papers receiving 1.6k citations

John E. Monahan's Hit Papers

An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide) 2013 · 439 citations
4390+4+8Years since publication100200300400

Peers

John E. Monahan
Comparison fields: 5 of 76
  • Cancer Research 271
  • Pulmonary and Respiratory Medicine 538
  • Molecular Biology 900
  • Endocrinology, Diabetes and Metabolism 183
  • Clinical Biochemistry 75
Replace Elizabeth Buck with:
Elizabeth Buck United States
G F Barnard United States
Hsiang‐Cheng Chi Taiwan
Lois L. Myeroff United States
Carole Sourbier United States
James Lutterbaugh United States
Karl‐Heinz Thierauch Germany
Anna Garuti Italy
Michael A. Shia United States
Yoko Takagi Japan
John E. Monahan relative to Elizabeth Buck United States Elizabeth Buck's profile →
Citations per field
00.5×1.5×2×
Elizabeth Buck · 1×
Citations per year

Countries citing papers authored by John E. Monahan

Since Specialization
Citations

This map shows the geographic impact of John E. Monahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Monahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Monahan more than expected).

Fields of papers citing papers by John E. Monahan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Monahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Monahan. The network helps show where John E. Monahan may publish in the future.

Co-authors

The 25 scholars most cited alongside John E. Monahan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Monahan Line = papers co-authored together John E. Monahan links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1
An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)
Hit paper breakdown →
2013439
2 2011214
3 1983194
4 1982190
5 2011102
6 198198
7 201088
8 201587
9 200974
10 201050
11 197750
12 200911
13 20156
14 20115
15 20104
16 20124
17 20121
18 20131
19 20141

About John E. Monahan

John E. Monahan is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Hematology and Gastroenterology, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Ubiquitin and proteasome pathways (1 paper), Animal Genetics and Reproduction (1 paper) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Cancer Research (271 citations), Pulmonary and Respiratory Medicine (538 citations), Molecular Biology (900 citations), Endocrinology, Diabetes and Metabolism (183 citations) and Clinical Biochemistry (75 citations). John E. Monahan has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Richard W. Hanson, H Yoo-Warren, Michele A. Cimbala, David A. Ruddy, William R. Sellers, Daniel P. Rakiec, Wouter H. Lamers, Joshua M. Korn, Ping Zhu and Frank Stegmeier. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Cancer Discovery, PLoS ONE and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact